HOME >> BIOLOGY >> NEWS
UNC-CH 'Groucho' Research Offers Insights Into How Embryo, Cancer Cells,,Communicate

By DAVID WILLIAMSON
UNC-CH News Services

CHAPEL HILL - Research on "whiskered" fruit flies containing proteins named after Groucho Marx has uncovered part of the way signaling mechanisms inside cells control what genes produce during normal development.

Because fruit flies and vertebrates, including humans, use essentially identical signals, the findings are a new and likely important step toward understanding how people and animals develop, scientists say. They also could help explain what goes wrong when cancer cells reproduce wildly and contribute to therapies that might reverse that deadly growth.

The research, conducted at the University of North Carolina at Chapel Hill and elsewhere, shows.

Groucho proteins and another family of proteins called Tcf interact to repress cells' internal signaling activity. That activity determines which genes are turned on, thus selecting what internal machinery cells will make. Normally, the process then informs cells what their role in life will be -- whether they will become part of an arm, for example, or part of a kidney.

"If the signaling pathway we are working on, which in fruit flies is called the 'wingless' pathway, is turned on continuously in humans in any of a variety of cell tissues such as in the colon, prostate or brain, that's the first step toward tumor development," said Dr. Mark Peifer, associate professor of biology at UNC-CH. "Our new work, aimed at learning in detail how genes get turned on and turned off normally, shows the process of controlling signals is a step more complicated than we thought.

"In a series of experiments, we found that Groucho and Tcf proteins act together to turn genes off like a light switch," Peifer said. "We already knew from earlier studies that we and others have done that Tcf proteins, when acting with another molecule called 'Armadillo,' turn genes on. Our hypothesis is that something very similar is happeni
'"/>

Contact: David Williamson
rdtokids@email.unc.edu
919-962-8596
University of North Carolina at Chapel Hill
21-Oct-1998


Page: 1 2 3

Related biology news :

1. UNC-CH study indicates special vaccines could prevent insulin-dependent diabetes
2. Feds give $16 million to UNC-CH scientists studying waste site problems
3. UNC-CH study offers new evidence that garlic protects against cancers
4. UNC-CH researchers to study social effects of N.C. hurricane
5. UNC-CH experiments reveal new pen can disinfect water
6. UNC-CH bus brings mobile lab, high-tech science focus to underserved N.C. schools
7. UNC-CH researchers to comb N.C. mountains for iron problem chiefly affecting Scots, Irish
8. UNC-CH biologists identify new order of marine fungi
9. UNC-CH scientists create worlds smallest pieces of ice
10. UNC-CH scientist finds smallest number of genes needed for organisms survival
11. UNC-CH scientist encourages all to watch PBS series on microbes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, ... a path for this task. Despite this uncertainty, several manufacturers have been successful and ... the first part of this webinar, learn how analytical similarity is achieved in biosimilars ...
(Date:3/27/2019)... ... 2019 , ... Evan Holden , a shareholder in the Atlanta ... at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), ... firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice , addressed, “Medical ...
(Date:3/25/2019)... ... 25, 2019 , ... Researchers have found multiple applications for ... came into use by the scientific community. Keck Graduate Institute (KGI) Assistant Professor ... combine the power of CRISPR’s nucleic acid targeting with the ultra sensitivity of ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:4/4/2019)... ... 03, 2019 , ... LeadingBiotech, an exclusive event series bringing ... its Boston CEO conference to be held May 28-29, 2019 at Boston’s Four ... high-level panels and discussions from past, present and future change-makers. , ...
(Date:3/27/2019)... ... ... In honor of National Nutrition Month, Lajollacooks4u has collaborated with the San Diego ... This month, Chef Jodi Abel appeared on two segments on KUSI’s Good Morning ... addressed the nutritional value of USDA’s MyPlate, a nutrition guide that simplifies the somewhat ...
(Date:3/23/2019)... , ... March 22, 2019 , ... ... LenS3 Multi-Angle Light Scattering (MALS) detector , offering a revolutionary approach for ... polymers, polysaccharides, proteins, and biopolymers. A novel optical design, a unique cell-block assembly, ...
Breaking Biology Technology:
Cached News: